Recognition underscores ACTO’s leadership in AI-powered field excellence and agentic AI purpose-built for Life Sciences TORONTO and NEW YORK–September 14, 2026 — ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced its inclusion in Everest Group’s Top 50™ Pharmaceutical Technology Providers for 2026, a global ranking of leading technology providers serving the pharmaceutical value chain. Everest Group’s … Read More The post ACTO Named Among Everest Group’s Top 50™ Pharmaceutical Technology Providers for 2026 appeared first on ACTO .